{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:15:14Z","timestamp":1785363314822,"version":"3.55.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-025-00501-5","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:42:28Z","timestamp":1742229748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A molecular systems architecture of neuromuscular junction in amyotrophic lateral sclerosis"],"prefix":"10.1038","volume":"11","author":[{"given":"V. A. Shiva","family":"Ayyadurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakar","family":"Deonikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-304X","authenticated-orcid":false,"given":"Roger D.","family":"Kamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"501_CR1","unstructured":"als amyotrophic lateral sclerosis - Search Results - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=als+amyotrophic+lateral+sclerosis+&filter=dates.1970%2F1%2F1-2024%2F11%2F1."},{"key":"501_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.4103\/aian.aian_397_22","volume":"25","author":"JS Koh","year":"2022","unstructured":"Koh, J. S., Fam, S. R., Ng, P. S. & Umapathi, T. ALS Treatment- We Still Await the \u201cMagic Cocktail. Ann. Indian Acad. Neurol. 25, 577 (2022).","journal-title":"Ann. Indian Acad. Neurol."},{"key":"501_CR3","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3390\/cells12111523","volume":"12","author":"L Tzeplaeff","year":"2023","unstructured":"Tzeplaeff, L., Wilfling, S., Requardt, M. V. & Herdick, M. Current State and Future Directions in the Therapy of ALS. Cells 12, 1523 (2023).","journal-title":"Cells"},{"key":"501_CR4","first-page":"1","volume":"12","author":"J Lombard","year":"2022","unstructured":"Lombard, J. & Hamper, M. Decoding Amyotrophic Lateral Sclerosis: A Systems Biology Approach. J. Restor. Med. 12, 1 (2022).","journal-title":"J. Restor. Med."},{"key":"501_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nn.4288","volume":"19","author":"MD Sweeney","year":"2016","unstructured":"Sweeney, M. D., Ayyadurai, S. & Zlokovic, B. V. Pericytes of the neurovascular unit: Key functions and signaling pathways. Nature Neurosci. 19, 771\u2013783 (2016).","journal-title":"Nature Neurosci."},{"key":"501_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/cancers14030756","volume":"14","author":"VAS Ayyadurai","year":"2022","unstructured":"Ayyadurai, V. A. S., Deonikar, P., McLure, K. G. & Sakamoto, K. M. Molecular Systems Architecture of Interactome in the Acute Myeloid Leukemia Microenvironment. Cancers (Basel). 14, 756 (2022).","journal-title":"Cancers (Basel)."},{"key":"501_CR7","first-page":"100026","volume":"2","author":"VAS Ayyadurai","year":"2023","unstructured":"Ayyadurai, V. A. S., Deonikar, P. & Stashenko, P. Molecular systems architecture of host-microbiome interactions in periodontitis. JADA Found. Sci. 2, 100026 (2023).","journal-title":"JADA Found. Sci."},{"key":"501_CR8","first-page":"571","volume":"06","author":"P Deonikar","year":"2015","unstructured":"Deonikar, P. et al. Discovery of Key Molecular Pathways of C1 Metabolism and Formaldehyde Detoxification in Maize through a Systematic Bioinformatics Literature Review. Agric. Sci. 06, 571\u2013585 (2015).","journal-title":"Agric. Sci."},{"key":"501_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/J.CLNESP.2022.03.010","volume":"49","author":"VAS Ayyadurai","year":"2022","unstructured":"Ayyadurai, V. A. S., Deonikar, P. & Bannuru, R. R. Attenuation of low-grade chronic inflammation by phytonutrients: A computational systems biology analysis. Clin. Nutr. ESPEN 49, 425\u2013435, https:\/\/doi.org\/10.1016\/J.CLNESP.2022.03.010 (2022).","journal-title":"Clin. Nutr. ESPEN"},{"key":"501_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/nu15030733","volume":"15","author":"VAS Ayyadurai","year":"2023","unstructured":"Ayyadurai, V. A. S., Deonikar, P. & Fields, C. Mechanistic Understanding of D-Glucaric Acid to Support Liver Detoxification Essential to Muscle Health Using a Computational Systems Biology Approach. Nutrients 15, 733 (2023).","journal-title":"Nutrients"},{"key":"501_CR11","doi-asserted-by":"publisher","first-page":"99.e7","DOI":"10.1016\/j.neurobiolaging.2020.08.017","volume":"99","author":"C Ungaro","year":"2021","unstructured":"Ungaro, C. et al. Genetic investigation of amyotrophic lateral sclerosis patients in south Italy: a two-decade analysis. Neurobiol. Aging 99, 99.e7\u201399.e14 (2021).","journal-title":"Neurobiol. Aging"},{"key":"501_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.neuron.2016.04.005","volume":"90","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS\/FTD. Neuron 90, 521\u2013534 (2016).","journal-title":"Neuron"},{"key":"501_CR13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1523\/JNEUROSCI.4434-08.2009","volume":"29","author":"L Kong","year":"2009","unstructured":"Kong, L. et al. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J. Neurosci. 29, 842\u2013851 (2009).","journal-title":"J. Neurosci."},{"key":"501_CR14","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/jnr.24231","volume":"96","author":"KB Santosa","year":"2018","unstructured":"Santosa, K. B., Keane, A. M., Jablonka-Shariff, A., Vannucci, B. & Snyder-Warwick, A. K. Clinical Relevance of Terminal Schwann Cells: An Overlooked Component of the Neuromuscular Junction. J. Neurosci. Res. 96, 1125 (2018).","journal-title":"J. Neurosci. Res."},{"key":"501_CR15","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/s41591-021-01346-1","volume":"27","author":"P Mohassel","year":"2022","unstructured":"Mohassel, P. et al. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. Nat Med 27, 1197\u20131204 (2022).","journal-title":"Nat Med"},{"key":"501_CR16","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori, P. & Van Damme, P. Amyotrophic lateral sclerosis: a clinical review. Eur. J. Neurol. 27, 1918 (2020).","journal-title":"Eur. J. Neurol."},{"key":"501_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.mcn.2016.12.001","volume":"80","author":"F Rinaldi","year":"2017","unstructured":"Rinaldi, F., Motti, D., Ferraiuolo, L. & Kaspar, B. K. High content analysis in amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 80, 180\u2013191 (2017).","journal-title":"Mol. Cell. Neurosci."},{"key":"501_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/1673-5374.314289","volume":"17","author":"MN Zakharova","year":"2022","unstructured":"Zakharova, M. N. & Abramova, A. A. Lower and upper motor neuron involvement and their impact on disease prognosis in amyotrophic lateral sclerosis. Neural Regen. Res. 17, 65\u201373 (2022).","journal-title":"Neural Regen. Res."},{"key":"501_CR19","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3390\/ijms20112818","volume":"20","author":"MAJ van den Bos","year":"2019","unstructured":"van den Bos, M. A. J., Geevasinga, N., Higashihara, M., Menon, P. & Vucic, S. Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques. Int. J. Mol. Sci. 20, 2818 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"501_CR20","doi-asserted-by":"publisher","first-page":"1047897","DOI":"10.3389\/fnagi.2023.1047897","volume":"15","author":"YM Jeon","year":"2023","unstructured":"Jeon, Y. M., Kwon, Y., Lee, S. & Kim, H. J. Potential roles of the endoplasmic reticulum stress pathway in amyotrophic lateral sclerosis. Front. Aging Neurosci. 15, 1047897 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"501_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2018.07.005","volume":"122","author":"CS Evans","year":"2019","unstructured":"Evans, C. S. & Holzbaur, E. L. F. Autophagy and Mitophagy in ALS. Neurobiol. Dis. 122, 35 (2019).","journal-title":"Neurobiol. Dis."},{"key":"501_CR22","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.3390\/cimb45040217","volume":"45","author":"L L\u00f3pez-Pingarr\u00f3n","year":"2023","unstructured":"L\u00f3pez-Pingarr\u00f3n, L. et al. Role of Oxidative Stress on the Etiology and Pathophysiology of Amyotrophic Lateral Sclerosis (ALS) and Its Relation with the Enteric Nervous System. Curr. Issues Mol. Biol. 45, 3315 (2023).","journal-title":"Curr. Issues Mol. Biol."},{"key":"501_CR23","doi-asserted-by":"publisher","first-page":"839526","DOI":"10.3389\/fcimb.2022.839526","volume":"12","author":"S Martin","year":"2022","unstructured":"Martin, S., Battistini, C. & Sun, J. A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men. Front. Cell. Infect. Microbiol. 12, 839526 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"501_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","volume":"572","author":"E Blacher","year":"2019","unstructured":"Blacher, E. et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature 572, 474\u2013480 (2019).","journal-title":"Nature"},{"key":"501_CR25","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/joa.13463","volume":"241","author":"A Alhindi","year":"2022","unstructured":"Alhindi, A., Boehm, I. & Chaytow, H. Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS). J. Anat. 241, 1089\u20131107 (2022).","journal-title":"J. Anat."},{"key":"501_CR26","doi-asserted-by":"publisher","first-page":"15286","DOI":"10.3390\/ijms140815286","volume":"14","author":"F Trojsi","year":"2013","unstructured":"Trojsi, F., Monsurr\u00f2, M. R. & Tedeschi, G. Exposure to environmental toxicants and pathogenesis of amyotrophic lateral sclerosis: state of the art and research perspectives. Int. J. Mol. Sci. 14, 15286\u201315311 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"501_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ncl.2015.07.009","volume":"33","author":"B Oskarsson","year":"2015","unstructured":"Oskarsson, B., Horton, D. K. & Mitsumoto, H. Potential Environmental Factors in Amyotrophic Lateral Sclerosis. Neurol. Clin. 33, 877 (2015).","journal-title":"Neurol. Clin."},{"key":"501_CR28","doi-asserted-by":"publisher","first-page":"610964","DOI":"10.3389\/fnmol.2020.610964","volume":"13","author":"PM Rodr\u00edguez Cruz","year":"2020","unstructured":"Rodr\u00edguez Cruz, P. M., Cossins, J., Beeson, D. & Vincent, A. The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis. Front. Mol. Neurosci. 13, 610964 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"501_CR29","first-page":"1","volume":"8","author":"X Chen","year":"2023","unstructured":"Chen, X., Shi, C., He, M., Xiong, S. & Xia, X. Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. Signal Transduct. Target. Ther. 2023 81 8, 1\u201340 (2023).","journal-title":"Signal Transduct. Target. Ther. 2023 81"},{"key":"501_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/febs.14358","volume":"286","author":"D Afroze","year":"2019","unstructured":"Afroze, D. & Kumar, A. ER Stress in Skeletal Muscle Remodeling and Myopathies. FEBS J 286, 379 (2019).","journal-title":"FEBS J"},{"key":"501_CR31","doi-asserted-by":"publisher","first-page":"1105247","DOI":"10.3389\/fncel.2023.1105247","volume":"17","author":"MS Karvandi","year":"2023","unstructured":"Karvandi, M. S., Sheikhzadeh Hesari, F., Aref, A. R. & Mahdavi, M. The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and neuroinflammation. Front. Cell. Neurosci. 17, 1105247 (2023).","journal-title":"Front. Cell. Neurosci."},{"key":"501_CR32","doi-asserted-by":"publisher","first-page":"13171","DOI":"10.1074\/jbc.M110.197483","volume":"286","author":"H Suzuki","year":"2011","unstructured":"Suzuki, H., Lee, K. & Matsuoka, M. TDP-43-induced death is associated with altered regulation of BIM and Bcl-xL and attenuated by caspase-mediated TDP-43 cleavage. J. Biol. Chem. 286, 13171\u201313183 (2011).","journal-title":"J. Biol. Chem."},{"key":"501_CR33","doi-asserted-by":"publisher","first-page":"772226","DOI":"10.3389\/fnmol.2021.772226","volume":"14","author":"L de Mena","year":"2021","unstructured":"de Mena, L., Lopez-Scarim, J. & Rincon-Limas, D. E. TDP-43 and ER Stress in Neurodegeneration: Friends or Foes? Front. Mol. Neurosci. 14, 772226 (2021).","journal-title":"Front. Mol. Neurosci."},{"key":"501_CR34","doi-asserted-by":"publisher","first-page":"653688","DOI":"10.3389\/fncel.2021.653688","volume":"15","author":"R Dafinca","year":"2021","unstructured":"Dafinca, R., Barbagallo, P. & Talbot, K. The Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS. Front. Cell. Neurosci. 15, 653688 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"501_CR35","first-page":"881","volume":"07","author":"H Yoshida","year":"2001","unstructured":"Yoshida, H. et al. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. cell. comH Yoshida, T Matsui, A Yamamoto, T Okada, K MoriCell 07, 881\u201391 (2001).","journal-title":"cell. comH Yoshida, T Matsui, A Yamamoto, T Okada, K MoriCell"},{"key":"501_CR36","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1101\/gad.1640108","volume":"22","author":"H Nishitoh","year":"2008","unstructured":"Nishitoh, H. et al. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 22, 1451\u20131464 (2008).","journal-title":"Genes Dev."},{"key":"501_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0824-1","volume":"7","author":"F Mori","year":"2019","unstructured":"Mori, F. et al. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathol. Commun. 7, 1\u201312 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"501_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.stem.2015.09.020","volume":"18","author":"V Zismanov","year":"2016","unstructured":"Zismanov, V. et al. Phosphorylation of eIF2\u03b1 Is a Translational Control Mechanism Regulating Muscle Stem Cell Quiescence and Self-Renewal. Cell Stem Cell 18, 79\u201390 (2016).","journal-title":"Cell Stem Cell"},{"key":"501_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1172\/JCI18330","volume":"113","author":"J Du","year":"2004","unstructured":"Du, J. et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J. Clin. Invest. 113, 115\u2013123 (2004).","journal-title":"J. Clin. Invest."},{"key":"501_CR40","doi-asserted-by":"publisher","first-page":"e1002321","DOI":"10.1371\/journal.pgen.1002321","volume":"7","author":"Z Yu","year":"2011","unstructured":"Yu, Z. et al. Macroautophagy is regulated by the UPR-mediator CHOP and accentuates the phenotype of SBMA mice. PLoS Genet 7, e1002321 (2011).","journal-title":"PLoS Genet"},{"key":"501_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-physiol-022516-034255","volume":"80","author":"L Li","year":"2018","unstructured":"Li, L., Xiong, W. C. & Mei, L. Neuromuscular Junction Formation, Aging, and Disorders. Annu. Rev. Physiol. 80, 159\u2013188 (2018).","journal-title":"Annu. Rev. Physiol."},{"key":"501_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.24272\/j.issn.2095-8137.2022.356","volume":"44","author":"WY Tu","year":"2023","unstructured":"Tu, W. Y. et al. C9orf72 poly-GA proteins impair neuromuscular transmission. Zool. Res. 44, 331 (2023).","journal-title":"Zool. Res."},{"key":"501_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","volume":"135","author":"N Kim","year":"2008","unstructured":"Kim, N. et al. Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 135, 334\u2013342 (2008).","journal-title":"Cell"},{"key":"501_CR44","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/ijms19020490","volume":"19","author":"SJ Burden","year":"2018","unstructured":"Burden, S. J., Huijbers, M. G. & Remedio, L. Fundamental Molecules and Mechanisms for Forming and Maintaining Neuromuscular Synapses. Int. J. Mol. Sci. 19, 490 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"501_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bone.2015.05.012","volume":"80","author":"C Shen","year":"2015","unstructured":"Shen, C., Xiong, W. C. & Mei, L. LRP4 in neuromuscular junction and bone development and diseases. Bone 80, 101\u2013108 (2015).","journal-title":"Bone"},{"key":"501_CR46","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/mus.25438","volume":"55","author":"MH Rivner","year":"2017","unstructured":"Rivner, M. H. et al. Agrin and LRP4 antibodies in Amyotrophic Lateral Sclerosis Patients. Muscle Nerve 55, 430 (2017).","journal-title":"Muscle Nerve"},{"key":"501_CR47","first-page":"1","volume":"11","author":"S L\u00e9pine","year":"2022","unstructured":"L\u00e9pine, S., Castellanos-Montiel, M. J. & Durcan, T. M. TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis. Transl. Neurodegener. 2022 111 11, 1\u201324 (2022).","journal-title":"Transl. Neurodegener. 2022 111"},{"key":"501_CR48","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.3390\/ijms21114021","volume":"21","author":"F Limanaqi","year":"2020","unstructured":"Limanaqi, F. et al. Cell-Clearing Systems Bridging Repeat Expansion Proteotoxicity and Neuromuscular Junction Alterations in ALS and SBMA. Int. J. Mol. Sci. 21, 4021 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"501_CR49","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neuron.2020.03.005","volume":"106","author":"V Gerbino","year":"2020","unstructured":"Gerbino, V. et al. The Loss of TBK1 Kinase Activity in Motor Neurons or in All Cell Types Differentially Impacts ALS Disease Progression in SOD1 Mice. Neuron 106, 789\u2013805.e5 (2020).","journal-title":"Neuron"},{"key":"501_CR50","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/15548627.2019.1569441","volume":"15","author":"WY Ho","year":"2019","unstructured":"Ho, W. Y. et al. The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy. Autophagy 15, 827\u2013842 (2019).","journal-title":"Autophagy"},{"key":"501_CR51","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/15548627.2018.1432327","volume":"14","author":"V Valenzuela","year":"2018","unstructured":"Valenzuela, V., Nassif, M. & Hetz, C. Unraveling the role of motoneuron autophagy in ALS. Autophagy 14, 733 (2018).","journal-title":"Autophagy"},{"key":"501_CR52","doi-asserted-by":"publisher","first-page":"1142617","DOI":"10.3389\/fnagi.2023.1142617","volume":"15","author":"BI Nilaver","year":"2023","unstructured":"Nilaver, B. I. & Urbanski, H. F. Mechanisms underlying TDP-43 pathology and neurodegeneration: An updated Mini-Review. Front. Aging Neurosci. 15, 1142617 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"501_CR53","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1089\/ars.2009.2444","volume":"11","author":"E Foran","year":"2009","unstructured":"Foran, E. & Trotti, D. Glutamate Transporters and the Excitotoxic Path to Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis. Antioxid. Redox Signal. 11, 1587 (2009).","journal-title":"Antioxid. Redox Signal."},{"key":"501_CR54","doi-asserted-by":"publisher","first-page":"15430","DOI":"10.3390\/ijms242015430","volume":"24","author":"F Provenzano","year":"2023","unstructured":"Provenzano, F., Torazza, C., Bonifacino, T., Bonanno, G. & Milanese, M. The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity. Int. J. Mol. Sci. 24, 15430 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"501_CR55","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1021\/acs.jmedchem.2c01572","volume":"66","author":"IC Fontana","year":"2023","unstructured":"Fontana, I. C. et al. A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases. J. Med. Chem. 66, 2330\u20132346 (2023).","journal-title":"J. Med. Chem."},{"key":"501_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-3-319-55769-4_6","volume":"16","author":"LT Rosenblum","year":"2017","unstructured":"Rosenblum, L. T. & Trotti, D. EAAT2 and the molecular signature of amyotrophic lateral sclerosis. Adv. Neurobiol. 16, 117 (2017).","journal-title":"Adv. Neurobiol."},{"key":"501_CR57","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbadis.2012.11.013","volume":"1832","author":"A Spalloni","year":"2013","unstructured":"Spalloni, A., Nutini, M. & Longone, P. Role of the N-methyl-d-aspartate receptors complex in amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1832, 312\u2013322 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"501_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.abq0651","volume":"9","author":"P Banerjee","year":"2023","unstructured":"Banerjee, P. et al. Cell-autonomous immune dysfunction driven by disrupted autophagy in C9orf72-ALS iPSC-derived microglia contributes to neurodegeneration. Sci. Adv. 9, 1\u201320 (2023).","journal-title":"Sci. Adv."},{"key":"501_CR59","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3389\/fnins.2020.00575","volume":"14","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis. Front. Neurosci. 14, 575 (2020).","journal-title":"Front. Neurosci."},{"key":"501_CR60","doi-asserted-by":"crossref","unstructured":"Bowerman, M. et al. Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis. Hum. Mol. Genet. 24, 3440\u20133456 (2015).","DOI":"10.1093\/hmg\/ddv094"},{"key":"501_CR61","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1468-1331.2011.03623.x","volume":"19","author":"J Aebischer","year":"2012","unstructured":"Aebischer, J. et al. Elevated levels of IFN\u03b3 and LIGHT in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. Eur. J. Neurol. 19, 752\u2013759 (2012).","journal-title":"Eur. J. Neurol."},{"key":"501_CR62","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/cdd.2010.143","volume":"18","author":"J Aebischer","year":"2011","unstructured":"Aebischer, J. et al. IFN\u03b3 triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1. Cell Death Differ 18, 754\u2013768 (2011).","journal-title":"Cell Death Differ"},{"key":"501_CR63","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","volume":"119","author":"D Cai","year":"2004","unstructured":"Cai, D. et al. IKK\u03b2\/NF-\u03baB activation causes severe muscle wasting in mice. Cell 119, 285\u2013298 (2004).","journal-title":"Cell"},{"key":"501_CR64","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00109-008-0373-8","volume":"86","author":"H Li","year":"2008","unstructured":"Li, H., Malhotra, S. & Kumar, A. Nuclear Factor-kappa B Signaling in Skeletal Muscle Atrophy. J. Mol. Med. (Berl). 86, 1113 (2008).","journal-title":"J. Mol. Med. (Berl)."},{"key":"501_CR65","first-page":"11075","volume":"10","author":"W Ding","year":"2017","unstructured":"Ding, W., Jiang, J., Xu, J., Cao, Y. & Xu, L. MURF contributes to skeletal muscle atrophy through suppressing autophagy. Int. J. Clin. Exp. Pathol. 10, 11075 (2017).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"501_CR66","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neurobiolaging.2019.07.001","volume":"82","author":"M Meroni","year":"2019","unstructured":"Meroni, M. et al. Transforming growth factor beta 1 signaling is altered in the spinal cord and muscle of amyotrophic lateral sclerosis mice and patients. Neurobiol. Aging 82, 48\u201359 (2019).","journal-title":"Neurobiol. Aging"},{"key":"501_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21124291","volume":"21","author":"M Galbiati","year":"2020","unstructured":"Galbiati, M. et al. Multiple roles of transforming growth factor beta in amyotrophic lateral sclerosis. Int. J. Mol. Sci. 21, 1\u201317 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"501_CR68","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/ng.2772","volume":"45","author":"R Sartori","year":"2013","unstructured":"Sartori, R. et al. BMP signaling controls muscle mass. Nat. Genet. 45, 1309\u20131318 (2013).","journal-title":"Nat. Genet."},{"key":"501_CR69","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1083\/jcb.201211134","volume":"203","author":"CE Winbanks","year":"2013","unstructured":"Winbanks, C. E. et al. The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass. J. Cell Biol. 203, 345\u2013357 (2013).","journal-title":"J. Cell Biol."},{"key":"501_CR70","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1152\/ajpcell.00104.2009","volume":"296","author":"R Sartori","year":"2009","unstructured":"Sartori, R. et al. Smad2 and 3 transcription factors control muscle mass in adulthood. Am. J. Physiol. - Cell Physiol. 296, 1248\u20131257 (2009).","journal-title":"Am. J. Physiol. - Cell Physiol."},{"key":"501_CR71","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/biomedicines11040999","volume":"11","author":"A Chiarini","year":"2023","unstructured":"Chiarini, A., Gui, L., Viviani, C., Armato, U. & Dal Pr\u00e0, I. NLRP3 Inflammasome\u2019s Activation in Acute and Chronic Brain Diseases\u2014An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes. Biomedicines 11, 999 (2023).","journal-title":"Biomedicines"},{"key":"501_CR72","doi-asserted-by":"publisher","first-page":"8404","DOI":"10.3390\/ijms22168404","volume":"22","author":"M Sidoryk-W\u0119grzynowicz","year":"2021","unstructured":"Sidoryk-W\u0119grzynowicz, M. & Stru\u017cy\u0144ska, L. Astroglial and Microglial Purinergic P2X7 Receptor as a Major Contributor to Neuroinflammation during the Course of Multiple Sclerosis. Int. J. Mol. Sci. 22, 8404 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"501_CR73","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fncel.2014.00117","volume":"8","author":"D Brites","year":"2014","unstructured":"Brites, D. & Vaz, A. R. Microglia centered pathogenesis in ALS: insights in cell interconnectivity. Front. Cell. Neurosci. 8, 117 (2014).","journal-title":"Front. Cell. Neurosci."},{"key":"501_CR74","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/glia.22891","volume":"63","author":"S Johann","year":"2015","unstructured":"Johann, S. et al. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia 63, 2260\u20132273 (2015).","journal-title":"Glia"},{"key":"501_CR75","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mus.10191","volume":"26","author":"PL McGeer","year":"2002","unstructured":"McGeer, P. L. & McGeer, E. G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26, 459\u2013470 (2002).","journal-title":"Muscle Nerve"},{"key":"501_CR76","doi-asserted-by":"publisher","first-page":"499577","DOI":"10.3389\/fneur.2020.00279","volume":"11","author":"PA McCombe","year":"2020","unstructured":"McCombe, P. A., Lee, J. D., Woodruff, T. M. & Henderson, R. D. The Peripheral Immune System and Amyotrophic Lateral Sclerosis. Front. Neurol. 11, 499577 (2020).","journal-title":"Front. Neurol."},{"key":"501_CR77","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/21678421.2020.1813310","volume":"22","author":"M Wosiski-Kuhn","year":"2021","unstructured":"Wosiski-Kuhn, M., Caress, J. B., Cartwright, M. S., Hawkins, G. A. & Milligan, C. Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients. Amyotroph. Lateral Scler. Frontotemporal Degener. 22, 248\u2013259 (2021).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"501_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09097-1","volume":"7","author":"Y Hu","year":"2017","unstructured":"Hu, Y. et al. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci. Rep. 7, 9094 (2017).","journal-title":"Sci. Rep."},{"key":"501_CR79","doi-asserted-by":"publisher","first-page":"a020602","DOI":"10.1101\/cshperspect.a020602","volume":"7","author":"J Silver","year":"2015","unstructured":"Silver, J., Schwab, M. E. & Popovich, P. G. Central Nervous System Regenerative Failure: Role of Oligodendrocytes, Astrocytes, and Microglia. Cold Spring Harb. Perspect. Biol. 7, a020602 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"501_CR80","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nature00867","volume":"417","author":"KC Wang","year":"2002","unstructured":"Wang, K. C. et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417, 941\u2013944 (2002).","journal-title":"Nature"},{"key":"501_CR81","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.4103\/1673-5374.308077","volume":"16","author":"KL Marshall","year":"2021","unstructured":"Marshall, K. L. & Farah, M. Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders. Neural Regen. Res. 16, 1901 (2021).","journal-title":"Neural Regen. Res."},{"key":"501_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.03.008","volume":"189","author":"JC Koch","year":"2018","unstructured":"Koch, J. C. et al. ROCK inhibition in models of neurodegeneration and its potential for clinical translation. Pharmacol. Ther. 189, 1\u201321 (2018).","journal-title":"Pharmacol. Ther."},{"key":"501_CR83","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fneur.2020.00173","volume":"11","author":"JC Koch","year":"2020","unstructured":"Koch, J. C. et al. Compassionate Use of the ROCK Inhibitor Fasudil in Three Patients With Amyotrophic Lateral Sclerosis. Front. Neurol. 11, 173 (2020).","journal-title":"Front. Neurol."},{"key":"501_CR84","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00018-015-2087-8","volume":"73","author":"A Hamacher-Brady","year":"2015","unstructured":"Hamacher-Brady, A. & Brady, N. R. Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy. Cell. Mol. Life Sci. 2015 734 73, 775\u2013795 (2015).","journal-title":"Cell. Mol. Life Sci. 2015 734"},{"key":"501_CR85","first-page":"1","volume":"14","author":"A Magr\u00ec","year":"2023","unstructured":"Magr\u00ec, A. et al. ERK1\/2-dependent TSPO overactivation associates with the loss of mitophagy and mitochondrial respiration in ALS. Cell Death Dis. 2023 142 14, 1\u201310 (2023).","journal-title":"Cell Death Dis. 2023 142"},{"key":"501_CR86","doi-asserted-by":"publisher","first-page":"151179","DOI":"10.1016\/j.ejcb.2021.151179","volume":"100","author":"R Sahu","year":"2021","unstructured":"Sahu, R., Upadhayay, S. & Mehan, S. Inhibition of extracellular regulated kinase (ERK)-1\/2 signaling pathway in the prevention of ALS: Target inhibitors and influences on neurological dysfunctions. Eur. J. Cell Biol. 100, 151179 (2021).","journal-title":"Eur. J. Cell Biol."},{"key":"501_CR87","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu, T. X. & Rothenberg, M. E. MicroRNA. J. Allergy Clin. Immunol. 141, 1202\u20131207 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"501_CR88","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1007\/s10072-020-04773-z","volume":"41","author":"L Wang","year":"2020","unstructured":"Wang, L. & Zhang, L. MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development. Neurol. Sci. 41, 3569\u20133577 (2020).","journal-title":"Neurol. Sci."},{"key":"501_CR89","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/cells11030572","volume":"11","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis. Cells 11, 572 (2022).","journal-title":"Cells"},{"key":"501_CR90","doi-asserted-by":"publisher","first-page":"1131758","DOI":"10.3389\/fnins.2023.1131758","volume":"17","author":"Y Koike","year":"2023","unstructured":"Koike, Y. & Onodera, O. Implications of miRNAs dysregulation in amyotrophic lateral sclerosis: Challenging for clinical applications. Front. Neurosci. 17, 1131758 (2023).","journal-title":"Front. Neurosci."},{"key":"501_CR91","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3390\/cells11071186","volume":"11","author":"C Gomes","year":"2022","unstructured":"Gomes, C. et al. Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes. Cells 11, 1186 (2022).","journal-title":"Cells"},{"key":"501_CR92","doi-asserted-by":"publisher","first-page":"634355","DOI":"10.3389\/fcell.2021.634355","volume":"9","author":"M Barbosa","year":"2021","unstructured":"Barbosa, M. et al. Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons. Front. Cell Dev. Biol. 9, 634355 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"501_CR93","first-page":"3078","volume":"18","author":"C Zhou","year":"2019","unstructured":"Zhou, C. et al. MicroRNA-146a inhibits NF-\u03baB activation and pro-inflammatory cytokine production by regulating IRAK1 expression in THP-1 cells. Exp. Ther. Med. 18, 3078 (2019).","journal-title":"Exp. Ther. Med."},{"key":"501_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells12111450","volume":"12","author":"CF Valori","year":"2023","unstructured":"Valori, C. F., Sulmona, C., Brambilla, L. & Rossi, D. Astrocytes: Dissecting Their Diverse Roles in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Cells 12, 1\u201327 (2023).","journal-title":"Cells"},{"key":"501_CR95","unstructured":"Food and Drug Administration Center for Drug Evaluation and Research. Request for Determination of Exempt Status of Investigational New Drug Application (IND) for Cyto-001 as Treatment for Patients with Pancreatic Cancer (PIND: 118833). (2013)."},{"key":"501_CR96","unstructured":"Ramey, J. G., Ayyadurai, V. A. S. & Deonikar, P. Composition for Improving Joint Health, (2021)."},{"key":"501_CR97","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12195-010-0143-x","volume":"4","author":"VAS Ayyadurai","year":"2011","unstructured":"Ayyadurai, V. A. S. & Dewey, C. F. CytoSolve: A Scalable Computational Method for Dynamic Integration of Multiple Molecular Pathway Models. Cell. Mol. Bioeng. 4, 28\u201345 (2011).","journal-title":"Cell. Mol. Bioeng."},{"key":"501_CR98","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/j.bpj.2013.03.052","volume":"104","author":"A Koo","year":"2013","unstructured":"Koo, A. et al. In Silico Modeling of Shear-Stress-Induced Nitric Oxide Production in Endothelial Cells through Systems Biology. Biophys. J. 104, 2295\u20132306 (2013).","journal-title":"Biophys. J."},{"key":"501_CR99","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.clnesp.2021.09.012","volume":"46","author":"VAS Ayyadurai","year":"2021","unstructured":"Ayyadurai, V. A. S. & Deonikar, P. Bioactive compounds in green tea may improve transplant tolerance: A computational systems biology analysis. Clin. Nutr. ESPEN 46, 439\u2013452 (2021).","journal-title":"Clin. Nutr. ESPEN"},{"key":"501_CR100","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1109\/TBME.2011.2173245","volume":"58","author":"DA Nordsletten","year":"2011","unstructured":"Nordsletten, D. A., Yankama, B., Umeton, R., Ayyadurai, V. A. S. & Dewey, C. F. Multiscale mathematical modeling to support drug development. IEEE Trans. Biomed. Eng. 58, 3508\u201312, https:\/\/doi.org\/10.1109\/TBME.2011.2173245 (2011).","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"501_CR101","unstructured":"Ayyadurai, V. A. S., Deonikar, P., Ali, A., Rockel, J. & Kapoor, M. Molecular Systems Architecture of Human Knee Osteoarthritis. CytoSolve, Inc. https:\/\/cytosolve.com\/human-knee-osteoarthritis\/ (2020)."},{"key":"501_CR102","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/cancers14030756","volume":"14","author":"VAS Ayyadurai","year":"2022","unstructured":"Ayyadurai, V. A. S., Deonikar, P., McLure, K. G. & Sakamoto, K. M. Molecular Systems Architecture of Interactome in the Acute Myeloid Leukemia Microenvironment [Supplemental Material]. Cancers (Basel). 14, 756 (2022).","journal-title":"Cancers (Basel)."},{"key":"501_CR103","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/J.CLNESP.2022.03.010","volume":"49","author":"VAS Ayyadurai","year":"2022","unstructured":"Ayyadurai, V. A. S., Deonikar, P. & Bannuru, R. R. Attenuation of low-grade chronic inflammation by phytonutrients: A computational systems biology analysis [Supplemental Material]. Clin. Nutr. ESPEN 49, 425\u2013435, https:\/\/doi.org\/10.1016\/J.CLNESP.2022.03.010 (2022).","journal-title":"Clin. Nutr. ESPEN"},{"key":"501_CR104","first-page":"100026","volume":"2","author":"VAS Ayyadurai","year":"2023","unstructured":"Ayyadurai, V. A. S., Deonikar, P. & Stashenko, P. Molecular systems architecture of host-microbiome interactions in periodontitis [Supplemental Material].Sci JADA Found 2, 100026 (2023).","journal-title":"Sci JADA Found"},{"key":"501_CR105","first-page":"332","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ (Online) 339, 332\u2013336 (2009).","journal-title":"BMJ (Online)"},{"key":"501_CR106","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/brainsci13010151","volume":"13","author":"SK Suthar","year":"2023","unstructured":"Suthar, S. K. & Lee, S. Y. The Role of Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis: Identification of Signaling Pathways, Regulators, Molecular Interaction Networks, and Biological Functions through Bioinformatics. Brain Sci 13, 151 (2023).","journal-title":"Brain Sci"},{"key":"501_CR107","doi-asserted-by":"publisher","first-page":"147167","DOI":"10.1016\/j.gene.2023.147167","volume":"858","author":"HM van\u2019t Spijker","year":"2023","unstructured":"van\u2019t Spijker, H. M. & Almeida, S. How villains are made: The translation of dipeptide repeat proteins in C9ORF72-ALS\/FTD. Gene 858, 147167 (2023).","journal-title":"Gene"},{"key":"501_CR108","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-022-00591-3","volume":"18","author":"K Stoklund Dittlau","year":"2023","unstructured":"Stoklund Dittlau, K. et al. FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms. Mol. Neurodegener. 18, 5 (2023).","journal-title":"Mol. Neurodegener."},{"key":"501_CR109","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-023-00623-6","volume":"18","author":"A Ionescu","year":"2023","unstructured":"Ionescu, A., Altman, T. & Perlson, E. Looking for answers far away from the soma-the (un)known axonal functions of TDP-43, and their contribution to early NMJ disruption in ALS. Mol. Neurodegener. 18, 35 (2023).","journal-title":"Mol. Neurodegener."},{"key":"501_CR110","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s40263-023-01007-6","volume":"37","author":"DS Malar","year":"2023","unstructured":"Malar, D. S. et al. Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders. CNS Drugs 37, 399\u2013440 (2023).","journal-title":"CNS Drugs"},{"key":"501_CR111","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/ijms24021268","volume":"24","author":"S Haouari","year":"2023","unstructured":"Haouari, S. et al. Study of Ubiquitin Pathway Genes in a French Population with Amyotrophic Lateral Sclerosis: Focus on HECW1 Encoding the E3 Ligase NEDL1. Int. J. Mol. Sci. 24, 1268 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"501_CR112","doi-asserted-by":"publisher","first-page":"7674","DOI":"10.3390\/ijms24087674","volume":"24","author":"F Sandrelli","year":"2023","unstructured":"Sandrelli, F. & Bisaglia, M. Molecular and Physiological Determinants of Amyotrophic Lateral Sclerosis: What the DJ-1 Protein Teaches Us. Int. J. Mol. Sci. 24, 7674 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"501_CR113","doi-asserted-by":"publisher","first-page":"113496","DOI":"10.1016\/j.expneurol.2020.113496","volume":"335","author":"K Sieverding","year":"2021","unstructured":"Sieverding, K. et al. Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43G298S transgenic mice. Exp. Neurol. 335, 113496 (2021).","journal-title":"Exp. Neurol."},{"key":"501_CR114","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jphs.2023.05.002","volume":"152","author":"A Idera","year":"2023","unstructured":"Idera, A. et al. Wild-type and pathogenic forms of ubiquilin 2 differentially modulate components of the autophagy-lysosome pathways. J. Pharmacol. Sci. 152, 182\u2013192 (2023).","journal-title":"J. Pharmacol. Sci."},{"key":"501_CR115","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/genes13050893","volume":"13","author":"H K\u00f6lbel","year":"2022","unstructured":"K\u00f6lbel, H. et al. New Insights into the Neuromyogenic Spectrum of a Gain of Function Mutation in SPTLC1. Genes (Basel) 13, 893 (2022).","journal-title":"Genes (Basel)"},{"key":"501_CR116","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/bph.15276","volume":"178","author":"R Manzano","year":"2021","unstructured":"Manzano, R. et al. What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy. Br. J. Pharmacol. 178, 1279\u20131297 (2021).","journal-title":"Br. J. Pharmacol."},{"key":"501_CR117","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/dneu.22909","volume":"83","author":"V Petel L\u00e9gar\u00e9","year":"2023","unstructured":"Petel L\u00e9gar\u00e9, V. et al. Loss of mitochondrial Chchd10 or Chchd2 in zebrafish leads to an ALS-like phenotype and Complex I deficiency independent of the mitochondrial integrated stress response. Dev. Neurobiol. 83, 54\u201369 (2023).","journal-title":"Dev. Neurobiol."},{"key":"501_CR118","doi-asserted-by":"publisher","first-page":"e3002028","DOI":"10.1371\/journal.pbio.3002028","volume":"21","author":"Y Koike","year":"2023","unstructured":"Koike, Y. et al. TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS\/FTD risk gene, UNC13A. PLOS Biol 21, e3002028 (2023).","journal-title":"PLOS Biol"},{"key":"501_CR119","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s13311-022-01297-6","volume":"19","author":"MP Coleman","year":"2022","unstructured":"Coleman, M. P. Axon Biology in ALS: Mechanisms of Axon Degeneration and Prospects for Therapy. Neurotherapy 19, 1133\u20131144 (2022).","journal-title":"Neurotherapy"},{"key":"501_CR120","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1080\/15548627.2019.1635379","volume":"16","author":"A Donde","year":"2020","unstructured":"Donde, A. et al. Upregulation of ATG7 attenuates motor neuron dysfunction associated with depletion of TARDBP\/TDP-43. Autophagy 16, 672\u2013682 (2020).","journal-title":"Autophagy"},{"key":"501_CR121","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-019-0327-3","volume":"14","author":"V Bercier","year":"2019","unstructured":"Bercier, V. et al. Dynactin1 depletion leads to neuromuscular synapse instability and functional abnormalities. Mol. Neurodegener. 14, 6\u20138 (2019).","journal-title":"Mol. Neurodegener."},{"key":"501_CR122","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3390\/cells8080906","volume":"8","author":"E Lepore","year":"2019","unstructured":"Lepore, E., Casola, I., Dobrowolny, G. & Musar\u00f2, A. Neuromuscular junction as an entity of nerve-muscle communication. Cells 8, 906 (2019).","journal-title":"Cells"},{"key":"501_CR123","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1093\/hmg\/ddy204","volume":"27","author":"D Gonzalez","year":"2018","unstructured":"Gonzalez, D. et al. The inhibition of CTGF\/CCN2 activity improves muscle and locomotor function in a murine ALS model. Hum. Mol. Genet. 27, 2913\u20132926 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"501_CR124","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1093\/hmg\/ddz190","volume":"28","author":"MG Williamson","year":"2019","unstructured":"Williamson, M. G. et al. Neuronal over-expression of Oxr1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo. Hum. Mol. Genet. 28, 3584\u20133599 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"501_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-022-00322-0","volume":"11","author":"I Agrawal","year":"2022","unstructured":"Agrawal, I., Lim, Y. S., Ng, S. Y. & Ling, S. C. Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine. Transl. Neurodegener. 11, 1\u201327 (2022).","journal-title":"Transl. Neurodegener."},{"key":"501_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-023-00366-w","volume":"12","author":"H Nango","year":"2023","unstructured":"Nango, H. et al. Update on the pathological roles of prostaglandin E2 in neurodegeneration in amyotrophic lateral sclerosis. Transl. Neurodegener. 12, 1\u201315 (2023).","journal-title":"Transl. Neurodegener."},{"key":"501_CR127","doi-asserted-by":"crossref","unstructured":"Szeb\u00e9nyi, K. et al. A human proteogenomic-cellular framework identifies KIF5A as a modulator of astrocyte process integrity with relevance to ALS. Commun. Biol. 6, 1\u201314 (2023).","DOI":"10.1038\/s42003-023-05041-4"},{"key":"501_CR128","first-page":"2047","volume":"18","author":"SS Jiang","year":"2023","unstructured":"Jiang, S. S. et al. 5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis. Neural Regen. Res. 18, 2047\u20132055 (2023).","journal-title":"Neural Regen. Res."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00501-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:42:35Z","timestamp":1742229755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00501-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":128,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["501"],"URL":"https:\/\/doi.org\/10.1038\/s41540-025-00501-5","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.A.S. Ayyadurai, and P. Deonikar are employees of CytoSolve, Inc. R.D. Kamm is an employee of Massachusetts Institute of Technology.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}